nach oben

Acta Neurochirurgica

Erschienen in:

22.01.2019 | Case Report - Tumor - Meningioma

Combined hormonal influence of cyproterone acetate and nomegestrol acetate on meningioma: a case report

verfasst von: Pierre-Olivier Champagne, Thibault Passeri, Sebastien Froelich

Erschienen in: Acta Neurochirurgica | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Cyproterone acetate (CPA) is an antiandrogenic drug which has recently been recognized to promote the occurrence and growth of intracranial meningiomas. Nomegestrol acetate (NOMAC) is a widely used progestin-like drug that could be suggested as an alternative for patients taking CPA. We report a case of CPA-related meningioma for which relay from CPA to NOMAC led to further tumor growth and cessation of NOMAC-induced tumor shrinkage. We suggest NOMAC can have a similar effect than CPA on meningiomas. The use of NOMAC as replacement for CPA in the presence of a meningioma should be discouraged until further evidence becomes available on the role of NOMAC in such instances.

Gil M, Oliva B, Timoner J, Macia MA, Bryant V, de Abajo FJ (2011) Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study. Br J Clin Pharmacol 72:965–968CrossRefPubMedPubMedCentral

Goncalves AM, Page P, Domigo V, Meder JF, Oppenheim C (2010) Abrupt regression of a meningioma after discontinuation of cyproterone treatment. AJNR Am J Neuroradiol 31:1504–1505CrossRefPubMed

Bernat AL, Oyama K, Hamdi S, Mandonnet E, Vexiau D, Pocard M, George B, Froelich S (2015) Growth stabilization and regression of meningiomas after discontinuation of cyproterone acetate: a case series of 12 patients. Acta Neurochir 157:1741–1746CrossRefPubMed

Huang Q, Chen X, Zhu Y, Cao L, Riviere JE (2015) Pharmacokinetics, tissue distribution, and excretion of nomegestrol acetate in female rats. Eur J Drug Metab Pharmacokinet 40:435–442CrossRefPubMed

Yang LP, Plosker GL (2012) Nomegestrol acetate/estradiol: in oral contraception. Drugs 72:1917–1928CrossRefPubMed

Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neuro-Oncol 99:307–314CrossRef

O’Shea T, Crowley RK, Farrell M, MacNally S, Govender P, Feeney J, Gibney J, Sherlock M (2016) Growth of a progesterone receptor-positive meningioma in a female patient with congenital adrenal hyperplasia. Endocrinol Diabetes Metab Case Rep 2016:16–0054PubMedPubMedCentral

Heijboer AC, Netelenbos JC, Blankenstein MA (2009) Meningioma in untreated congenital adrenal hyperplasia: a relationship? J Neuro-Oncol 92:223–225CrossRef

Li X, Zhao J (2009) Intracranial meningiomas of childhood and adolescence: report of 34 cases with follow-up. Childs Nerv Syst 25:1411–1417CrossRef

10.

Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ (2003) Sex steroid hormone exposures and risk for meningioma. J Neurosurg 99:848–853CrossRefPubMed

11.

Seliger C, Meier CR, Becker C, Jick SS, Proescholdt M, Bogdahn U, Hau P, Leitzmann MF (2017) Metabolic syndrome in relation to risk of meningioma. Oncotarget 8:2284–2292CrossRefPubMed

12.

Shao C, Bai LP, Qi ZY, Hui GZ, Wang Z (2014) Overweight, obesity and meningioma risk: a meta-analysis. PLoS One 9:e90167CrossRefPubMedPubMedCentral

13.

Koper JW, Lamberts SW (1994) Meningiomas, epidermal growth factor and progesterone. Hum Reprod (Oxford, England) 9(Suppl 1):190–194CrossRef

14.

Guay DR (2009) Drug treatment of paraphilic and nonparaphilic sexual disorders. Clin Ther 31:1–31CrossRefPubMed

15.

Neumann F, Berswordt-Wallrabe RV, Elger W, Steinbeck H, Hahn JD, Kramer M (1970) Aspects of androgen-dependent events as studied by antiandrogens. Recent Prog Horm Res 26:337–410PubMed

16.

Froelich S, Dali-Youcef N, Boyer P, Kehrli P, Maitrot D, Auwerx J (2008) Does cyproterone acetate promote multiple meningiomas? 10th European Congress of Endocrinology, vol 16 Berlin, 158

17.

Lello S (2010) Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy. Drugs 70:541–559CrossRefPubMed

18.

Mueck AO, Sitruk-Ware R (2011) Nomegestrol acetate, a novel progestogen for oral contraception. Steroids 76:531–539CrossRefPubMed

19.

Durmaz R, Deliorman S, Isiksoy S, Uyar R, Tel E (1999) Luteinizing hormone releasing hormone increases proliferation of meningioma cells in vitro. Arch Physiol Biochem 107:286–291PubMed

20.

Lee KL, Terris MK (2003) Luteinizing hormone-releasing hormone agonists and meningioma: a treatment dilemma. Urology 62:351PubMed

21.

Cottin V, Vukusic S, Jouanneau E, Lazor R, Cordier J-F (2004) Should patients with lymphangioleiomyomatosis undergo screening for meningioma? Eur Respir J 24:888–889CrossRefPubMed

22.

Raudrant D, Rabe T (2003) Progestogens with antiandrogenic properties. Drugs 63:463–492CrossRefPubMed

23.

Shimizu J, Matsumoto M, Yamazaki E, Yasue M (2008) Spontaneous regression of an asymptomatic meningioma associated with discontinuation of progesterone agonist administration. Neurol Med Chir (Tokyo) 48:227–230CrossRef

Titel: Combined hormonal influence of cyproterone acetate and nomegestrol acetate on meningioma: a case report
verfasst von: Pierre-Olivier Champagne
Thibault Passeri
Sebastien Froelich
Publikationsdatum: 22.01.2019
Verlag: Springer Vienna
Erschienen in: Acta Neurochirurgica / Ausgabe 3/2019
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-018-03782-4

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

16.04.2024 | Maligne primäre ZNS-Tumoren | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Combined hormonal influence of cyproterone acetate and nomegestrol acetate on meningioma: a case report

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Simple Kortisontherapie stoppt primär progrediente Aphasie

Impostor-Syndrom häufig bei Hyperhidrose zu finden

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Early postoperative MRI after resection of brain metastases—complete tumour resection associated with prolonged survival

Unexpected immediate postoperative resolution of long-standing neurological deficits following extracranial-intracranial bypass: a report of three cases

The patient’s perspective: follow-up Foix-Chavany-Marie syndrome secondary to bilateral traumatic operculum injury

Correction to: Variation in neurosurgical management of traumatic brain injury: a survey in 68 centers participating in the CENTER-TBI study

Experiences with a temporary synthetic skin substitute after decompressive craniectomy: a retrospective two-center analysis

Influence of pregnancy on glioma patients

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Simple Kortisontherapie stoppt primär progrediente Aphasie

Impostor-Syndrom häufig bei Hyperhidrose zu finden

Update Neurologie